US Patent 9962333 Timed release of substances to treat ocular disorders
All edits
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+386 characters)
Article
Patent abstract
A system is disclosed for simple, non-invasive, sustained delivery of ophthalmic substances to the interior of the eye, for the prevention and treatment of eye diseases and conditions. Liposomes and inverted micelles are disclosed as suitable vehicles, and timed release of the substances is effected. Delivery methods include coating of a lens or injection into the eye.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Devi Kalyan Karumanchi0
Elizabeth Gaillard0
James Dillon0
Jason Friedrichs0
Tao Xu0
Timothy J. Hagen0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09962333 Timed release of substances to treat ocular disorders US Patent 9962333 Timed release of substances to treat ocular disorders
Infobox
Patent Number
09962333
Patent Number
9962333
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09962333 Timed release of substances to treat ocular disorders
Infobox
Is a
Patent jurisdiction
Patent number
09962333
Date of patent
May 8, 2018
Patent application number
14907745
Date Filed
August 14, 2014
Patent primary examiner
Find more entities like US Patent 9962333 Timed release of substances to treat ocular disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
